Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Cancer Research
|
October 5, 2001
Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines
H Gourdeau, M L Clarke, F Ouellet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 12, 2008
Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancer
D Santini, G Perrone, B Vincenzi, et al.
European Journal of Histochemistry : EJH
|
September 16, 2010
Human equilibrative nucleoside transporter 1 and carcinoma of the ampulla of Vater: expression differences in tumour histotypes
G Perrone, S Morini, D Santini, et al.
Science Translational Medicine
|
May 14, 2010
Metabolic modulation of glioblastoma with dichloroacetate
E D Michelakis, G Sutendra, P Dromparis, et al.
Pharmaceutical Biotechnology
|
April 1, 2000
Nucleoside transporters of mammalian cells
C E Cass, J D Young, S A Baldwin, et al.
British Journal of Cancer
|
August 22, 2014
Subgroup effects in a randomised trial of different types and doses of exercise during breast cancer chemotherapy
K S Courneya, D C McKenzie, J R Mackey, et al.
British Journal of Cancer
|
January 14, 2015
Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study
O K Glass, B A Inman, G Broadwater, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2016
Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial
J R Mackey, T Pieńkowski, J Crown, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2017
Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab
D Arnold, C S Fuchs, J Tabernero, et al.
British Journal of Cancer
|
March 11, 2018
Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy
N O Elander, K Aughton, P Ghaneh, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Cancer Research
|
October 5, 2001
Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines
H Gourdeau, M L Clarke, F Ouellet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 12, 2008
Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancer
D Santini, G Perrone, B Vincenzi, et al.
European Journal of Histochemistry : EJH
|
September 16, 2010
Human equilibrative nucleoside transporter 1 and carcinoma of the ampulla of Vater: expression differences in tumour histotypes
G Perrone, S Morini, D Santini, et al.
Science Translational Medicine
|
May 14, 2010
Metabolic modulation of glioblastoma with dichloroacetate
E D Michelakis, G Sutendra, P Dromparis, et al.
Pharmaceutical Biotechnology
|
April 1, 2000
Nucleoside transporters of mammalian cells
C E Cass, J D Young, S A Baldwin, et al.
British Journal of Cancer
|
August 22, 2014
Subgroup effects in a randomised trial of different types and doses of exercise during breast cancer chemotherapy
K S Courneya, D C McKenzie, J R Mackey, et al.
British Journal of Cancer
|
January 14, 2015
Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study
O K Glass, B A Inman, G Broadwater, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 5, 2016
Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial
J R Mackey, T Pieńkowski, J Crown, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 27, 2017
Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab
D Arnold, C S Fuchs, J Tabernero, et al.
British Journal of Cancer
|
March 11, 2018
Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy
N O Elander, K Aughton, P Ghaneh, et al.
Page
of 6